Financials
Financial year 2025
PHARMACIE ELSEN from Beauraing, company number BE0867387163, closed financial year 2025 with a result of € 14,784 after tax. For that financial year PHARMACIE ELSEN recorded a gross margin of € 38,433 and equity of € 144,411. Compared with financial year 2024, the result moved from € 41,931 to € 14,784. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 8, 2026.
€ 144,411
▲ 11% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 14,784
▼ 65% vs 2024
Profit after tax over the fiscal year.
€ 56,647
▼ 39% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 94,411.
People and assets in 2025
€ 1,960
▼ 53% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 165,263
▼ 16% vs 2024
€ 32,759 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.
€ 293,391
▲ 23% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 8,743
▼ 10% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 20,292 | € 46,117 | € 77,086 | € 38,433 | ▼ 50% |
| Profit after taxes | € 8,429 | € 23,703 | € 41,931 | € 14,784 | ▼ 65% |
| Equity | € 63,994 | € 87,697 | € 129,628 | € 144,411 | ▲ 11% |
| Total debts | € 417,715 | € 476,725 | € 479,480 | € 492,647 | ▲ 3% |
| Cash | € 130,549 | € 118,809 | € 93,354 | € 56,647 | ▼ 39% |
| Retained profit | € 13,994 | € 37,697 | € 79,628 | € 94,411 | ▲ 19% |
| Bank debt | € 140,128 | € 155,028 | € 197,085 | € 165,263 | ▼ 16% |
| Balance sheet total | € 481,709 | € 564,423 | € 609,108 | € 637,058 | ▲ 5% |
Key figures of PHARMACIE ELSEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE ELSEN?
What happened at PHARMACIE ELSEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 14,784 (▼ 65% vs 2024). Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Yvoir. KBO
In short
From € 8,429 profit in 2022 to € 14,784 profit in 2025.
Paid € 28,637 in corporate taxes since 2022.
Best year ever: 2024, with € 41,931 profit.
Management
The stake of DEJARDIN INVEST SRL comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE ELSENBehind PHARMACIE ELSEN is DEJARDIN INVEST SPRL. The shares are held by DEJARDIN INVEST SRL (100%).
Directors
According to the 2025 annual accounts
Director · represented by PIERRE DEJARDIN
Also active at: Pharmacie dejardin, PHARMACIE SAINTE-ANNE
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
rue de l'Aubépine 95
5570 Beauraing
Rue de l'Hôtel-de-Ville 6
5530 Yvoir
Active since 15 September 2004
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0867.387.163
- VAT number
- BE 0867.387.163
- Registered office
- rue de l'Aubépine 95, 5570 Beauraing
- Names & denominations
- PHARMACIE ELSEN
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 23 September 2004
- Peppol
- Active · Active since 18 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers